Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Loss of heterozygosity status of D9S105 marker is associated with downregulation of Kr?ppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.

Funel N, Morelli M, Giovannetti E, Del Chiaro M, Pollina LE, Mosca F, Boggi U, Cavazzana A, Campani D. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Kr?ppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions. Pancreatology. 2011; 11(1):30-42.

View in: PubMed

collapse authors with profiles


Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)